Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2057-3804
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction ; volume:6 ; number:1 ; day:23 ; month:7 ; year:2020 ; pages:1-8 ; date:12.2020
Cardio-Oncology ; 6, Heft 1 (23.7.2020), 1-8, 12.2020
- Creator
-
Planek, Maria Isabel Camara
Manshad, Ahmad
Hein, Kyaw
Hemu, Mohamad
Ballout, Fatima
Varandani, Rajiv
Venugopal, Parameswaran
Okwuosa, Tochukwu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-020-00066-8
- URN
-
urn:nbn:de:101:1-2020091620232571991066
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Planek, Maria Isabel Camara
- Manshad, Ahmad
- Hein, Kyaw
- Hemu, Mohamad
- Ballout, Fatima
- Varandani, Rajiv
- Venugopal, Parameswaran
- Okwuosa, Tochukwu
- SpringerLink (Online service)
Other Objects (12)
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
Vaccarin Ameliorates Doxorubicin-Induced Cardiotoxicity via Inhibition of p38 MAPK Mediated Mitochondrial Dysfunction
eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Doxorubicin cardiotoxicity and target cells: a broader perspective
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
Vaccarin Ameliorates Doxorubicin-Induced Cardiotoxicity via Inhibition of p38 MAPK Mediated Mitochondrial Dysfunction
eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Doxorubicin cardiotoxicity and target cells: a broader perspective
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
Vaccarin Ameliorates Doxorubicin-Induced Cardiotoxicity via Inhibition of p38 MAPK Mediated Mitochondrial Dysfunction
eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Doxorubicin cardiotoxicity and target cells: a broader perspective
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy